Is clopidogrel beneficial following coronary bypass surgery?

Area of Science:

• Cardiovascular Surgery
• Pharmacology
• Evidence-Based Medicine

Background:

• Coronary artery bypass grafting (CABG) is a common cardiac surgery.
• Preventing adverse events post-CABG is crucial for patient outcomes.
• Antiplatelet therapy with aspirin is standard, but alternatives are sought.

Purpose of the Study:

• To evaluate the efficacy of clopidogrel compared to aspirin in preventing adverse events following CABG.
• To identify the best available evidence regarding antiplatelet therapy post-coronary surgery.

Main Methods:

• A systematic literature search was conducted to identify relevant studies.
• A best evidence topic protocol was followed.
• Four high-quality papers were selected and analyzed for relevant outcomes and results.

Main Results:

• A total of 220 papers were initially identified.
• Four studies provided the best evidence for the clinical question.
• No strong evidence indicates clopidogrel is superior to aspirin post-coronary surgery.

Conclusions:

• Clopidogrel serves as a viable alternative when aspirin is not tolerated by patients post-CABG.
• The current evidence base does not definitively establish clopidogrel's superiority over aspirin in this context.